These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. MuSK IgG4 autoantibodies cause myasthenia gravis by inhibiting binding between MuSK and Lrp4. Huijbers MG; Zhang W; Klooster R; Niks EH; Friese MB; Straasheijm KR; Thijssen PE; Vrolijk H; Plomp JJ; Vogels P; Losen M; Van der Maarel SM; Burden SJ; Verschuuren JJ Proc Natl Acad Sci U S A; 2013 Dec; 110(51):20783-8. PubMed ID: 24297891 [TBL] [Abstract][Full Text] [Related]
4. Autoantibodies to low-density lipoprotein receptor-related protein 4 in myasthenia gravis. Higuchi O; Hamuro J; Motomura M; Yamanashi Y Ann Neurol; 2011 Feb; 69(2):418-22. PubMed ID: 21387385 [TBL] [Abstract][Full Text] [Related]
5. MuSK myasthenia gravis IgG4 disrupts the interaction of LRP4 with MuSK but both IgG4 and IgG1-3 can disperse preformed agrin-independent AChR clusters. Koneczny I; Cossins J; Waters P; Beeson D; Vincent A PLoS One; 2013; 8(11):e80695. PubMed ID: 24244707 [TBL] [Abstract][Full Text] [Related]
6. Characterization of pathogenic monoclonal autoantibodies derived from muscle-specific kinase myasthenia gravis patients. Takata K; Stathopoulos P; Cao M; Mané-Damas M; Fichtner ML; Benotti ES; Jacobson L; Waters P; Irani SR; Martinez-Martinez P; Beeson D; Losen M; Vincent A; Nowak RJ; O'Connor KC JCI Insight; 2019 Jun; 4(12):. PubMed ID: 31217355 [TBL] [Abstract][Full Text] [Related]
8. [Autoantibodies in myasthenia gravis]. Motomura M; Narita Masuda T Brain Nerve; 2013 Apr; 65(4):433-9. PubMed ID: 23568991 [TBL] [Abstract][Full Text] [Related]
9. Agonist antibody to MuSK protects mice from MuSK myasthenia gravis. Oury J; Gamallo-Lana B; Santana L; Steyaert C; Vergoossen DLE; Mar AC; Vankerckhoven B; Silence K; Vanhauwaert R; Huijbers MG; Burden SJ Proc Natl Acad Sci U S A; 2024 Sep; 121(39):e2408324121. PubMed ID: 39288173 [TBL] [Abstract][Full Text] [Related]
10. Myasthenia Gravis: Pathogenic Effects of Autoantibodies on Neuromuscular Architecture. Koneczny I; Herbst R Cells; 2019 Jul; 8(7):. PubMed ID: 31269763 [TBL] [Abstract][Full Text] [Related]
11. The role of muscle-specific tyrosine kinase (MuSK) and mystery of MuSK myasthenia gravis. Koneczny I; Cossins J; Vincent A J Anat; 2014 Jan; 224(1):29-35. PubMed ID: 23458718 [TBL] [Abstract][Full Text] [Related]
12. Autoantibodies to agrin in myasthenia gravis patients. Zhang B; Shen C; Bealmear B; Ragheb S; Xiong WC; Lewis RA; Lisak RP; Mei L PLoS One; 2014; 9(3):e91816. PubMed ID: 24632822 [TBL] [Abstract][Full Text] [Related]
13. Autoimmune Pathology in Myasthenia Gravis Disease Subtypes Is Governed by Divergent Mechanisms of Immunopathology. Fichtner ML; Jiang R; Bourke A; Nowak RJ; O'Connor KC Front Immunol; 2020; 11():776. PubMed ID: 32547535 [TBL] [Abstract][Full Text] [Related]
14. Antibody effector mechanisms in myasthenia gravis-pathogenesis at the neuromuscular junction. Gomez AM; Van Den Broeck J; Vrolix K; Janssen SP; Lemmens MA; Van Der Esch E; Duimel H; Frederik P; Molenaar PC; Martínez-Martínez P; De Baets MH; Losen M Autoimmunity; 2010 Aug; 43(5-6):353-70. PubMed ID: 20380584 [TBL] [Abstract][Full Text] [Related]
15. IgG4 autoantibodies against muscle-specific kinase undergo Fab-arm exchange in myasthenia gravis patients. Koneczny I; Stevens JA; De Rosa A; Huda S; Huijbers MG; Saxena A; Maestri M; Lazaridis K; Zisimopoulou P; Tzartos S; Verschuuren J; van der Maarel SM; van Damme P; De Baets MH; Molenaar PC; Vincent A; Ricciardi R; Martinez-Martinez P; Losen M J Autoimmun; 2017 Feb; 77():104-115. PubMed ID: 27965060 [TBL] [Abstract][Full Text] [Related]